GWAS |
- Alzheimer's disease (late onset) ( 30820047)
- Alzheimer's disease or family history of Alzheimer's disease ( 33589840 30617256)
- Apolipoprotein A1 levels ( 32203549)
- Chronotype ( 30696823)
- Diffusing capacity of carbon monoxide ( 30694715)
- Family history of Alzheimer's disease ( 30617256)
- Levodopa-induced dyskinesia in levodopa treated Parkinson's disease ( 32733355)
- Metabolite levels ( 23823483)
- Schizophrenia ( 30285260)
|
- Acne (severe) ( 24927181)
- Cough in response to angiotensin-converting enzyme inhibitor drugs ( 28084903)
- Hair shape ( 29220522)
- Hand grip strength ( 29691431 29313844)
- Heel bone mineral density ( 30598549)
- Hip minimal joint space width ( 27701424)
- Longevity ( 20834067)
- Low hand grip strength (60 years and older) (EWGSOP) ( 33510174)
- Low hand grip strength (60 years and older) (FNIH) ( 33510174)
- Neutrophil count ( 21507922)
- Obesity-related traits ( 23251661)
- Osteoarthritis ( 30664745)
- Pulse pressure in young-onset hypertension ( 24892410)
- Response to citalopram or escitalopram in depression ( 27622933)
- Response to esketamine in treatment resistant depression ( 32724131)
- Severe progression in rheumatoid arthritis ( 29065906)
- Superior frontal gyrus grey matter volume ( 25335168)
|